Chromocell Therapeutics Corp CHRO 深 滬
已收盤 07-01 16:00:00 美东时间
1.35
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 1.35
- 總市值 890.45万
- 52周最高 38.00
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 4.50
- 委 比 0.00%
- 總股本 659.59万
- 歷史最高 60.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 4.50
- 每 手 1
- 風險率 3.27%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Chromocell Therapeutics Merges and Becomes Pelthos Therapeutics
The latest update is out from Chromocell Therapeutics Corp ( ($CHRO) ). On July...
2025-07-03 05:49
Channel Therapeutics Announces 10-For-1 Reverse Split Ahead Of LNHC Merger, $50M Investment Led By Murchinson
Channel Therapeutics Corporation, ("Channel" or the "Company"), (NYSE:CHRO), an emerging leader in the development of non-opioid pain treatment therapeutics, today announced a 10-for-one reverse split (the "Reverse Stock
2025-06-27 21:17
Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement
Channel Therapeutics Corporation announced a 10-for-1 reverse stock split to increase its share price and meet NYSE American listing requirements ahead of a $50 million merger with LNHC, Inc. The split will reduce the number of outstanding shares from ~6.5 million to ~648,501, effective before market open on July 1, with trading resuming on July 2 under the name "Pelthos Therapeutics Inc." Shareholders' ownership percentages remain unchanged, and...
2025-06-27 13:15
EXCLUSIVE: Channel Therapeutics Touts Positive Efficacy Results For Eye Treatment Potential In Multiple Preclinical In Vivo Models
Channel Therapeutics reports CT2000 reduced eye pain in preclinical trials, with plans to enter human testing for acute and chronic indications.
2025-05-14 19:59
Chromocell Therapeutics Q1 GAAP EPS $(0.32) Misses $(0.31) Estimate
Chromocell Therapeutics (AMEX:CHRO) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 41.82 percent increase over losses of $(0.55) per share
2025-05-14 05:58
Chromocell Therapeutics Faces Going Concern Disclosure
Chromocell Therapeutics Corp ( ($CHRO) ) has shared an announcement. Channel Th...
2025-05-02 05:28
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Channel Therapeutics (AMEX:CHRO) stock increased by 86.5% to $2.34 dur...
2025-04-17 20:09
Chromocell Therapeutics Rebrands to Focus on Pain Treatments
Chromocell Therapeutics Corp ( ($CHRO) ) just unveiled an update. Channel Thera...
2024-11-21 22:28
Chromocell Therapeutics Merges into Channel Therapeutics
Chromocell Therapeutics Corp ( ($CHRO) ) has provided an announcement. Chromoce...
2024-11-19 06:27
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock increased by 16.8% to $0....
2024-09-27 04:31
